Pharmacokinetics and Pharmacodynamic Effects of an Oral Ghrelin Agonist in Healthy Subjects
Open Access
- 1 May 2007
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 92 (5), 1814-1820
- https://doi.org/10.1210/jc.2006-2160
Abstract
Context: An oral formulation of EP01572, a peptidomimetic growth hormone secretagogue, was studied. An oral delivery system would be preferable in many of the possible therapeutic indications of ghrelin agonists such as EP01572. Objectives: Our objective was to establish the pharmacological profile and the GH-releasing activity of increasing oral doses of EP01572 in healthy volunteers. In addition, the pharmacokinetics and pharmacological effects of EP01572 were investigated after intraduodenal (ID) administration. Setting: This study was a single-center escalating dose study with oral and ID applications. Subjects and Methods: In the first part, EP01572 was given orally to 36 male subjects; the treatment consisted of one oral dose of either EP01572 or placebo (0.005, 0.05, and 0.5 mg/kg body weight). Six subjects received two additional oral doses of EP01572: 0.125 and 0.25 mg/kg body weight. In the second part, the following treatments were performed in a randomized order: 1) administration of a bolus of saline (placebo) to the small intestine; 2) ID administration of a bolus of EP01572 at 0.2 mg/kg body weight; 3) ID perfusion of a bolus of EP01572 at 0.35 mg/kg body weight; and 4) ID perfusion of a bolus of EP01572 at 0.5 mg/kg body weight. Results: The oral and ID administration of EP01572 induced a rapid and dose-dependent increase in plasma drug concentrations and a potent GH release in healthy male volunteers. Conclusions: This study showed that EP01572 was active with regard to stimulation of GH release in humans after oral and ID administration.Keywords
This publication has 22 references indexed in Scilit:
- Plasma Ghrelin Levels after Diet-Induced Weight Loss or Gastric Bypass SurgeryThe New England Journal of Medicine, 2002
- Ghrelin Is Present in Pancreatic α-Cells of Humans and Rats and Stimulates Insulin SecretionDiabetes, 2002
- Ghrelin Enhances Appetite and Increases Food Intake in HumansJournal of Clinical Endocrinology & Metabolism, 2001
- Chronic Administration of Ghrelin Improves Left Ventricular Dysfunction and Attenuates Development of Cardiac Cachexia in Rats With Heart FailureCirculation, 2001
- Hemodynamic and hormonal effects of human ghrelin in healthy volunteersAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- Ghrelin-induced growth hormone secretion in humansActa Endocrinologica, 2000
- Ghrelin Strongly Stimulates Growth Hormone Release in HumansJournal of Clinical Endocrinology & Metabolism, 2000
- The Novel Hypothalamic Peptide Ghrelin Stimulates Food Intake and Growth Hormone SecretionEndocrinology, 2000
- Ghrelin, a Novel Growth Hormone-Releasing Acylated Peptide, Is Synthesized in a Distinct Endocrine Cell Type in the Gastrointestinal Tracts of Rats and Humans1Endocrinology, 2000
- Ghrelin is a growth-hormone-releasing acylated peptide from stomachNature, 1999